Today’s top gainers include the company AstraZeneca PLC (NYSE:AZN) which is in the industry Drug Manufacturers – Major, gaining -0.71% today. In the last week its performance is -2.85%, and 7.58% for the past quarter. Currently, AstraZeneca PLC, AZN has a target price of 36.09, so today’s gain of -0.71% is a significant step towards its target price. The GAP today is therefore -0.84%.
AstraZeneca PLC (NYSE:AZN), has a market cap of 81111.8, and is based in United Kingdom. Insider ownership is at 0.50%, and institutional ownership is 12.20%.
At the current price of 32.06, it has a dividend yield of 2.81%, and its target price is 36.09. This is with a profit margin of 9.20%, and total debt/equity of 1.3. AstraZeneca PLC (NYSE:AZN) has a P/E of 36.51, as well as a forward P/E of 10.98.
With a current EPS of 0.88, and a forecasted EPS growth for next year at -11.86%,AstraZeneca PLC (NYSE:AZN) has had a EPS growth for the past five years at -16.70%. For the next five years EPS growth is projected to be -1.00%.
Performance for the year is 4.06%. Since its IPO date on 5/17/1993, the total performance to date is -1.21%.
Volume today for AstraZeneca PLC (NYSE:AZN), is 3690500, while its average volume is 5952.25. Whilst the total gain today was -0.71%, it did have a day high of -7.28%.
Volatility for this week has been at 1.23%, and 1.38% for the month. The 52-week low for AstraZeneca PLC, AZN has been 20.46%, while the 52-week-high has reached -7.28%.
Looking at its return of investments, which is 11.50%, and its return on assets is 3.70%. AstraZeneca PLC (NYSE:AZN) has an operating margin of 15.00%. With a sales growth of -11.20% quarter over quarter. Bearing in mind that AstraZeneca PLC, AZN is in the sector Healthcare, its long-term debt/equity is 1.22, and has a current ratio of 0.9 and 0.8 for quick ratio.
So what is the value of AstraZeneca PLC? Well its PEG is *TBA, and the P/S is 3.37, along with a P/B of 5.99. Meanwhile it has a p/cash of 17.46.